55 results
6-K
EX-99.1
IFRX
InflaRx N.V.
28 Jun 24
Leerink Partners LLC
4:55pm
relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants
6-K
EX-99.2
IFRX
InflaRx N.V.
5 Jun 24
InflaRx Hosts R&D Event Highlighting the Promise of INF904
5:07pm
with other innate immune receptors to promote a pro-inflammatory environment TLR Synergistic effects on Inflammation Autoimmunity Infection Prof. Dr
6-K
EX-99.2
IFRX
InflaRx N.V.
8 May 24
Report of Foreign Private Issuer
8:43am
statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible
6-K
EX-99.2
IFRX
InflaRx N.V.
1 Nov 23
Current report (foreign)
8:04am
results to differ materially from those expressed or implied by our forward-looking statements. Moreover, we operate in an evolving environment. New risk
6-K
EX-99.3
pxwkqq9697il dvr
1 Nov 23
Current report (foreign)
8:04am
6-K
EX-99.2
54ob2vw91u
10 Aug 23
Report of Foreign Private Issuer
8:00am
6-K
EX-99.3
w1y42sjemrc5pn
10 Aug 23
Report of Foreign Private Issuer
8:00am
6-K
EX-99.3
zso9n5tc
11 May 23
Current report (foreign)
8:00am
6-K
EX-99.2
higs58o1l ud
11 May 23
Current report (foreign)
8:00am
6-K
EX-1.1
fao3vg6okq
13 Apr 23
Current report (foreign)
4:01pm
424B5
q4ixq8p
13 Apr 23
Prospectus supplement for primary offering
8:48am
424B5
l14diou5
11 Apr 23
Prospectus supplement for primary offering
4:11pm
6-K
EX-99.2
mpcvn
9 Nov 22
Current report (foreign)
7:52am
6-K
EX-99.4
dhsjuorca
9 Nov 22
Current report (foreign)
7:52am
6-K
EX-99.3
vegt1w2e9
5 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.2
8bbb5
5 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
043rbe7i
5 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
2hhro2ib6 v7n
12 May 22
Current report (foreign)
8:30am
6-K
EX-99.2
19febyy 4kkhm1ag0
12 May 22
Current report (foreign)
8:30am